Six-minute walk test and pulmonary function in ambulatory children with early-onset scoliosis

Karina A Zapata1, Charles E Johnston2, Tiffany H Thompson2

  • 1Scottish Rite for Children, 2222 Welborn Street, Dallas, TX, 75219, USA. Karina.zapata@tsrh.org.

Spine Deformity
|October 16, 2025
PubMed

Insights

Children with early-onset scoliosis (EOS) show significantly reduced aerobic function on the six-minute walk test (6MWT) compared to controls. This objective measure correlates with pulmonary function, highlighting a need for further research.

Area of Science:

  • Pediatric Orthopedics
  • Pulmonology
  • Rehabilitation Medicine

Background:

  • The six-minute walk test (6MWT) is a key measure of aerobic capacity.
  • Normative data for the 6MWT in early-onset scoliosis (EOS) populations is lacking.
  • Understanding functional ambulation in EOS is crucial for assessing treatment efficacy.

Purpose of the Study:

  • To establish normative 6MWT distances and standard deviations (SD) for children with EOS compared to age- and sex-matched controls.
  • To investigate correlations between 6MWT performance and pulmonary function tests (PFTs) in EOS patients.
  • To evaluate differences in 6MWT distances between EOS subtypes (congenital, idiopathic, neuromuscular, syndromic).

Main Methods:

  • Retrospective review of 163 ambulatory children with EOS who underwent 6MWT and PFTs (Forced Vital Capacity [FVC]% and Forced Expiratory Volume in one second [FEV1]%) between 2012 and 2023.
  • Comparison of 6MWT distances and SDs against age- and sex-matched healthy controls.
  • Analysis of correlations between 6MWT distance and PFT parameters (FVC%, FEV1%).

Main Results:

  • Children with EOS walked significantly shorter distances on the 6MWT compared to controls, with only 12% falling within 1 SD of the mean.
  • Congenital/Idiopathic (C/I) EOS subgroups walked farther than Neuromuscular/Syndromic (N/S) subgroups but still demonstrated clinically significant deficits compared to controls.
  • 6MWT distance showed significant positive correlations with FEV1% (r=0.29, p=0.001) and FVC% (r=0.27, p=0.003).

Conclusions:

  • The 6MWT provides an objective assessment of functional ambulation in EOS patients and correlates with pulmonary function.
  • Despite better performance than N/S subtypes, C/I EOS patients exhibit substantial aerobic functional compromise.
  • The current lack of objective functional data hinders the evaluation of treatment effectiveness in EOS, underscoring the need for multi-center prospective studies.
Abstract